Latest news with #ThomasGlanzmann
Business Wire
30-05-2025
- Business
- Business Wire
Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC ('Mason'), a registered investment advisor to funds and accounts holding approximately 3% of Grifols S.A. ('Grifols' or the 'Company') (BME: GRF) (NASDAQ: GRFS) class A shares, today announced that it sent a letter to the Grifols Board of Directors (the 'Board') expressing Mason's support for the Company's recommended slate of director candidates for election at the Ordinary General Shareholders' Meeting to be held on June 4 and 5, 2025. The full text of the letter follows: Grifols, S.A. Avinguda de la Generalitat 152-158 08174 Sant Cugat del Vallès Barcelona – SPAIN Dear Grifols Board Members: Mason Capital owns ~3% of Grifols A shares. We are aligned with the current Board and are supportive of the recommended slate of director candidates for election at the AGM. We appreciate the constructive dialogue with Board members to date, particularly Tomas Daga, the retiring Thomas Glanzmann, and the incoming chairwoman Anne Berner. Grifols has amalgamated world class assets over its long history and benefits from an excellent management team that is executing on an achievable 5-year plan. Mason believes board leadership continuity and continued management focus will lead to a much higher stock price over time, as more long-only investors engage with Grifols shares. Regards, Kenneth M Garschina Managing Member Mason Capital Management About Mason Capital Management LLC Mason Capital Management LLC is an absolute return focused investment firm that combines deep fundamental analysis with hard catalysts to drive value creation. Founded in July 2000 by Ken Garschina and Mike Martino, Mason's strategies range from event-driven investing to corporate carve-outs and control acquisitions.
Yahoo
06-05-2025
- Business
- Yahoo
Alcon Announces Results of 2025 Annual General Meeting
Shareholders approve all agenda items presented Deborah Di Sanzo elected as new member of the Board 2024 Compensation Report and Report on Non-Financial Matters approved in advisory votes GENEVA, May 06, 2025--(BUSINESS WIRE)--Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2025 Annual General Meeting ("AGM"). A total of 332,704,408 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 13,308,176.32, were represented at today's AGM. Shareholders re-elected F. Michael Ball as member and Chair of the Board of Directors, and the other members of the Board who stood for re-election, namely Lynn Bleil, Arthur Cummings, David Endicott, Thomas Glanzmann, D. Keith Grossman, Scott Maw, Karen May, Ines Pöschel and Dieter Spälti, for a term of office of one year. Shareholders also elected Deborah Di Sanzo to the Board, effective as of September 1, 2025. In addition, shareholders re-elected Thomas Glanzmann, Karen May, Scott Maw and Ines Pöschel to form the Compensation Committee for a period of one year. Discharge was granted to the members of the Board of Directors and the members of the Executive Committee for the 2024 financial year. In two separate binding votes, shareholders approved the maximum aggregate amount of compensation of the Board of Directors for the next term of office ending at the 2026 Annual General Meeting, and the Executive Committee for 2026 financial year. Shareholders also accepted the 2024 Report on Non-Financial Matters and the 2024 Compensation Report in separate, non-binding, consultative votes. Alcon shareholders approved the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2024. Shareholders also approved that a gross dividend of CHF 0.28 per dividend-bearing share be declared, and that, after appropriation of the dividend, the remaining amount of available earnings be carried forward. PricewaterhouseCoopers SA, Geneva, was re-elected as statutory auditors for the 2025 financial year. Hartmann Dreyer Attorneys-at-Law was also re-elected as the independent representative for a term of one year extending until the 2026 AGM. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at
Business Wire
06-05-2025
- Business
- Business Wire
Alcon Announces Results of 2025 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2025 Annual General Meeting ('AGM'). A total of 332,704,408 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 13,308,176.32, were represented at today's AGM. Shareholders re-elected F. Michael Ball as member and Chair of the Board of Directors, and the other members of the Board who stood for re-election, namely Lynn Bleil, Arthur Cummings, David Endicott, Thomas Glanzmann, D. Keith Grossman, Scott Maw, Karen May, Ines Pöschel and Dieter Spälti, for a term of office of one year. Shareholders also elected Deborah Di Sanzo to the Board, effective as of September 1, 2025. In addition, shareholders re-elected Thomas Glanzmann, Karen May, Scott Maw and Ines Pöschel to form the Compensation Committee for a period of one year. Discharge was granted to the members of the Board of Directors and the members of the Executive Committee for the 2024 financial year. In two separate binding votes, shareholders approved the maximum aggregate amount of compensation of the Board of Directors for the next term of office ending at the 2026 Annual General Meeting, and the Executive Committee for 2026 financial year. Shareholders also accepted the 2024 Report on Non-Financial Matters and the 2024 Compensation Report in separate, non-binding, consultative votes. Alcon shareholders approved the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2024. Shareholders also approved that a gross dividend of CHF 0.28 per dividend-bearing share be declared, and that, after appropriation of the dividend, the remaining amount of available earnings be carried forward. PricewaterhouseCoopers SA, Geneva, was re-elected as statutory auditors for the 2025 financial year. Hartmann Dreyer Attorneys-at-Law was also re-elected as the independent representative for a term of one year extending until the 2026 AGM. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at
Bloomberg
25-02-2025
- Business
- Bloomberg
Grifols Names Independent Director Berner as Its Chairwoman
Grifols SA has named an independent director to become non-executive chairwoman, the Spanish company's latest step to improve its corporate governance. Anne-Catherine Berner, who joined the board in May 2024, will be appointed as non-executive chairwoman right after the next annual shareholders' meeting, according to a regulatory filing. Current Chairman Thomas Glanzmann, who has served on the board for 19 years, will not seek reelection.
